The goal of the proposed studies is to understand mechanisms of mucosal defense by characterizing antibacterial peptide components of mouse Paneth cells and their effects on pathogenic microorganisms. Cryptdin is one of several Paneth cell defensins, and cryptdin and other enteric defensins are hypothesized to constitute a family of antimicrobial peptides produced by these epithelial granulocytes to protect against invasion and colonization of the small bowel by bacteria. Experiments are proposed to isolate cryptdin and intestinal defensins from small bowel and determine their antibacterial activities in vitro, to characterize enteric defensin genes in Paneth cells, and to define genetic loci in Salmonella typhimurium that confer resistance to cryptdin and enteric defensins. Specifically, one series of objectives is to purify cellular and secreted forms of intestinal defensins from mouse small bowel and determine their peptide sequences, to characterize natural and synthetic intestinal defensins with regard to antimicrobial activity against virulent and avirulent strains of enteric pathogens, and to determine their cellular, sub cellular, and extracellular distribution using light and electron microscopic immunohistochemical techniques. Secondly, cDNAs corresponding to enteric defensins will be isolated and characterized, the intestinal cells that express such sequence will be identified by in situ hybridization, and the structure and organization of the murine cryptdin gene family will be defined. Thirdly, the relationship between resistance to enteric defensins and Salmonella virulence will be investigated by analyzing genetic loci of S. typhimurium that confer resistance to cryptdins, by identifying S. typhimurium phoP mutants with suppressor mutations of the cryptdin sensitive phenotype and determining the genetic basis of the reversion, by characterizing bacterial genes and proteins that confer resistance to cryptdins, and by constructing S. typhimurium strains with mutations in genes essential to cryptdin resistance. By delineating the role of enteric defensins in the mucosal barrier, the factors that regulate their expression, and specific mechanisms of resistance to cryptdins, a component of mucosal host defense will have been characterized at the level of the peptide effectors, the genes encoding the peptides, and the molecular targets of the peptides in the microorganism. Completion of these aims should provide insight into molecular mechanisms of intestinal defense against enteric bacterial pathogens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK044632-03
Application #
2143949
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1993-05-01
Project End
1996-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Cobo, Eduardo R; Holani, Ravi; Moreau, France et al. (2018) Entamoeba histolytica Alters ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency. Infect Immun :
Tai, Kenneth P; Kamdar, Karishma; Yamaki, Jason et al. (2015) Microbicidal effects of ?- and ?-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Innate Immun 21:17-29
Mastroianni, Jennifer R; Lu, Wuyuan; Selsted, Michael E et al. (2014) Differential Susceptibility of Bacteria to Mouse Paneth Cell ?-Defensins under Anaerobic Conditions. Antibiotics (Basel) 3:493-508
Tai, Kenneth P; Le, Valerie V; Selsted, Michael E et al. (2014) Hydrophobic determinants of ?-defensin bactericidal activity. Infect Immun 82:2195-202
Patil, Amar A; Ouellette, Andre J; Lu, Wuyuan et al. (2013) Rattusin, an intestinal ?-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities. Antimicrob Agents Chemother 57:1823-31
Schmidt, Nathan W; Tai, Kenneth P; Kamdar, Karishma et al. (2012) Arginine in ?-defensins: differential effects on bactericidal activity correspond to geometry of membrane curvature generation and peptide-lipid phase behavior. J Biol Chem 287:21866-72
Tongaonkar, Prasad; Golji, Amir E; Tran, Patti et al. (2012) High fidelity processing and activation of the human ?-defensin HNP1 precursor by neutrophil elastase and proteinase 3. PLoS One 7:e32469
Mastroianni, Jennifer R; Costales, Jessica K; Zaksheske, Jennifer et al. (2012) Alternative luminal activation mechanisms for paneth cell ?-defensins. J Biol Chem 287:11205-12
Burkhardt, Amanda M; Tai, Kenneth P; Flores-Guiterrez, Juan P et al. (2012) CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol 188:6399-406
Andersson, Håkan S; Figueredo, Sharel M; Haugaard-Kedström, Linda M et al. (2012) The ?-defensin salt-bridge induces backbone stability to facilitate folding and confer proteolytic resistance. Amino Acids 43:1471-83

Showing the most recent 10 out of 27 publications